These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17457898)

  • 1. PELD allocation and acute liver/graft failure.
    Sindhi R; Soltys K; Bond G; Marcos A; Mazariegos G
    Liver Transpl; 2007 May; 13(5):776-7. PubMed ID: 17457898
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 3. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality risk, behavior, and pediatric liver allocation.
    Freeman RB
    Liver Transpl; 2006 Jan; 12(1):12-5. PubMed ID: 16382452
    [No Abstract]   [Full Text] [Related]  

  • 5. MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease.
    Wiesner RH
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S17-22. PubMed ID: 15382286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver allocation: the intent-to-treat approach.
    Freeman RB
    Transpl Int; 2006 Apr; 19(4):270-4. PubMed ID: 16573541
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
    Shneider BL; Neimark E; Frankenberg T; Arnott L; Suchy FJ; Emre S
    Liver Transpl; 2005 Jul; 11(7):788-795. PubMed ID: 15973720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following liver transplantation.
    Ryckman FC; Bucuvalas JC; Nathan J; Alonso M; Tiao G; Balistreri WF
    Semin Pediatr Surg; 2008 May; 17(2):123-30. PubMed ID: 18395662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The donor liver allocation system: a model for end-stage liver disease.
    Wu J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):330-1. PubMed ID: 15313662
    [No Abstract]   [Full Text] [Related]  

  • 10. Selection of live-related liver transplantation candidates.
    Rymeski BA; Flynn L; Dunn SP
    J Pediatr Surg; 2009 Jun; 44(6):1096-100; discussion 1100-1. PubMed ID: 19524723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
    Sheiner P; Belghiti J; Gish RG; Miller C
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
    [No Abstract]   [Full Text] [Related]  

  • 12. MELD--an imperfect, but thus far the best, solution to the problem of organ allocation.
    Lake JR
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):5-7. PubMed ID: 18392236
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Indian J Pediatr; 2007 Apr; 74(4):387-92. PubMed ID: 17476086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.
    Olthoff KM; Brown RS; Delmonico FL; Freeman RB; McDiarmid SV; Merion RM; Millis JM; Roberts JP; Shaked A; Wiesner RH; Lucey MR
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):A6-22. PubMed ID: 15382225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The model for end-stage liver disease comes of age.
    Freeman RB
    Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Best get a shot at extra time?
    Salvage J
    Nurs Times; 2002 Aug 13-19; 98(33):18. PubMed ID: 12211760
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Child-Turcotte-Pugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation.
    Dehghani SM; Gholami S; Bahador A; Haghighat M; Imanieh MH; Nikeghbalian S; Salahi H; Davari HR; Mehrabani D; Malek-Hosseini SA
    Transplant Proc; 2007 Dec; 39(10):3175-7. PubMed ID: 18089346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the numbers: rational and ethical application of outcome models for organ allocation in liver transplantation.
    Biggins SW
    Liver Transpl; 2007 Aug; 13(8):1080-3. PubMed ID: 17663407
    [No Abstract]   [Full Text] [Related]  

  • 20. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.
    Gitto S; Lorenzini S; Biselli M; Conti F; Andreone P; Bernardi M
    Dig Liver Dis; 2009 Oct; 41(10):700-6. PubMed ID: 19502118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.